In tongue squamous cell carcinoma (TSCC), exosomal miR-200c may be an effective strategy for suppressing chemoresistance to docetaxel, as it inhibits TUBB3 and PPP2R1B [8]. This evidence concerns the gene TUBB3 and tongue squamous cell carcinoma.